 SOUTH SAN FRANCISCO, Calif., Sept. 16, 2021 PRNewswire -- Sutro Biopharma, Inc. NASDAQ: STRO, a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, announced today the appointment of two executives to the Companys leadership team. 